Request for Covid-19 Impact Assessment of this Report
The United States Verapamil market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Verapamil market, reaching US$ million by the year 2028. As for the Europe Verapamil landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Verapamil players cover REPLEK FARM, Mylan, Abbott Laboratories, and YUNGSHIN PHARM IND. CO. LTD, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Verapamil market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablets
Capsules
Injection
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacy
Retail Pharmacy
Online Sales
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
REPLEK FARM
Mylan
Abbott Laboratories
YUNGSHIN PHARM IND. CO. LTD
The Central Pharmaceutical CO.,Ltd.Tianjin
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Verapamil Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Verapamil by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Verapamil by Country/Region, 2017, 2022 & 2028
2.2 Verapamil Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.2.3 Injection
2.2.4 Others
2.3 Verapamil Sales by Type
2.3.1 Global Verapamil Sales Market Share by Type (2017-2022)
2.3.2 Global Verapamil Revenue and Market Share by Type (2017-2022)
2.3.3 Global Verapamil Sale Price by Type (2017-2022)
2.4 Verapamil Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Sales
2.4.4 Others
2.5 Verapamil Sales by Application
2.5.1 Global Verapamil Sale Market Share by Application (2017-2022)
2.5.2 Global Verapamil Revenue and Market Share by Application (2017-2022)
2.5.3 Global Verapamil Sale Price by Application (2017-2022)
3 Global Verapamil by Company
3.1 Global Verapamil Breakdown Data by Company
3.1.1 Global Verapamil Annual Sales by Company (2020-2022)
3.1.2 Global Verapamil Sales Market Share by Company (2020-2022)
3.2 Global Verapamil Annual Revenue by Company (2020-2022)
3.2.1 Global Verapamil Revenue by Company (2020-2022)
3.2.2 Global Verapamil Revenue Market Share by Company (2020-2022)
3.3 Global Verapamil Sale Price by Company
3.4 Key Manufacturers Verapamil Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Verapamil Product Location Distribution
3.4.2 Players Verapamil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Verapamil by Geographic Region
4.1 World Historic Verapamil Market Size by Geographic Region (2017-2022)
4.1.1 Global Verapamil Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Verapamil Annual Revenue by Geographic Region
4.2 World Historic Verapamil Market Size by Country/Region (2017-2022)
4.2.1 Global Verapamil Annual Sales by Country/Region (2017-2022)
4.2.2 Global Verapamil Annual Revenue by Country/Region
4.3 Americas Verapamil Sales Growth
4.4 APAC Verapamil Sales Growth
4.5 Europe Verapamil Sales Growth
4.6 Middle East & Africa Verapamil Sales Growth
5 Americas
5.1 Americas Verapamil Sales by Country
5.1.1 Americas Verapamil Sales by Country (2017-2022)
5.1.2 Americas Verapamil Revenue by Country (2017-2022)
5.2 Americas Verapamil Sales by Type
5.3 Americas Verapamil Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Verapamil Sales by Region
6.1.1 APAC Verapamil Sales by Region (2017-2022)
6.1.2 APAC Verapamil Revenue by Region (2017-2022)
6.2 APAC Verapamil Sales by Type
6.3 APAC Verapamil Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Verapamil by Country
7.1.1 Europe Verapamil Sales by Country (2017-2022)
7.1.2 Europe Verapamil Revenue by Country (2017-2022)
7.2 Europe Verapamil Sales by Type
7.3 Europe Verapamil Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Verapamil by Country
8.1.1 Middle East & Africa Verapamil Sales by Country (2017-2022)
8.1.2 Middle East & Africa Verapamil Revenue by Country (2017-2022)
8.2 Middle East & Africa Verapamil Sales by Type
8.3 Middle East & Africa Verapamil Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Verapamil
10.3 Manufacturing Process Analysis of Verapamil
10.4 Industry Chain Structure of Verapamil
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Verapamil Distributors
11.3 Verapamil Customer
12 World Forecast Review for Verapamil by Geographic Region
12.1 Global Verapamil Market Size Forecast by Region
12.1.1 Global Verapamil Forecast by Region (2023-2028)
12.1.2 Global Verapamil Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Verapamil Forecast by Type
12.7 Global Verapamil Forecast by Application
13 Key Players Analysis
13.1 REPLEK FARM
13.1.1 REPLEK FARM Company Information
13.1.2 REPLEK FARM Verapamil Product Offered
13.1.3 REPLEK FARM Verapamil Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 REPLEK FARM Main Business Overview
13.1.5 REPLEK FARM Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Verapamil Product Offered
13.2.3 Mylan Verapamil Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Verapamil Product Offered
13.3.3 Abbott Laboratories Verapamil Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 YUNGSHIN PHARM IND. CO. LTD
13.4.1 YUNGSHIN PHARM IND. CO. LTD Company Information
13.4.2 YUNGSHIN PHARM IND. CO. LTD Verapamil Product Offered
13.4.3 YUNGSHIN PHARM IND. CO. LTD Verapamil Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 YUNGSHIN PHARM IND. CO. LTD Main Business Overview
13.4.5 YUNGSHIN PHARM IND. CO. LTD Latest Developments
13.5 The Central Pharmaceutical CO.,Ltd.Tianjin
13.5.1 The Central Pharmaceutical CO.,Ltd.Tianjin Company Information
13.5.2 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Offered
13.5.3 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 The Central Pharmaceutical CO.,Ltd.Tianjin Main Business Overview
13.5.5 The Central Pharmaceutical CO.,Ltd.Tianjin Latest Developments
14 Research Findings and Conclusion
Table 1. Verapamil Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Verapamil Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsules
Table 5. Major Players of Injection
Table 6. Major Players of Others
Table 7. Global Verapamil Sales by Type (2017-2022) & (K Units)
Table 8. Global Verapamil Sales Market Share by Type (2017-2022)
Table 9. Global Verapamil Revenue by Type (2017-2022) & ($ million)
Table 10. Global Verapamil Revenue Market Share by Type (2017-2022)
Table 11. Global Verapamil Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Verapamil Sales by Application (2017-2022) & (K Units)
Table 13. Global Verapamil Sales Market Share by Application (2017-2022)
Table 14. Global Verapamil Revenue by Application (2017-2022)
Table 15. Global Verapamil Revenue Market Share by Application (2017-2022)
Table 16. Global Verapamil Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Verapamil Sales by Company (2020-2022) & (K Units)
Table 18. Global Verapamil Sales Market Share by Company (2020-2022)
Table 19. Global Verapamil Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Verapamil Revenue Market Share by Company (2020-2022)
Table 21. Global Verapamil Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Verapamil Producing Area Distribution and Sales Area
Table 23. Players Verapamil Products Offered
Table 24. Verapamil Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Verapamil Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Verapamil Sales Market Share Geographic Region (2017-2022)
Table 29. Global Verapamil Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Verapamil Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Verapamil Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Verapamil Sales Market Share by Country/Region (2017-2022)
Table 33. Global Verapamil Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Verapamil Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Verapamil Sales by Country (2017-2022) & (K Units)
Table 36. Americas Verapamil Sales Market Share by Country (2017-2022)
Table 37. Americas Verapamil Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Verapamil Revenue Market Share by Country (2017-2022)
Table 39. Americas Verapamil Sales by Type (2017-2022) & (K Units)
Table 40. Americas Verapamil Sales Market Share by Type (2017-2022)
Table 41. Americas Verapamil Sales by Application (2017-2022) & (K Units)
Table 42. Americas Verapamil Sales Market Share by Application (2017-2022)
Table 43. APAC Verapamil Sales by Region (2017-2022) & (K Units)
Table 44. APAC Verapamil Sales Market Share by Region (2017-2022)
Table 45. APAC Verapamil Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Verapamil Revenue Market Share by Region (2017-2022)
Table 47. APAC Verapamil Sales by Type (2017-2022) & (K Units)
Table 48. APAC Verapamil Sales Market Share by Type (2017-2022)
Table 49. APAC Verapamil Sales by Application (2017-2022) & (K Units)
Table 50. APAC Verapamil Sales Market Share by Application (2017-2022)
Table 51. Europe Verapamil Sales by Country (2017-2022) & (K Units)
Table 52. Europe Verapamil Sales Market Share by Country (2017-2022)
Table 53. Europe Verapamil Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Verapamil Revenue Market Share by Country (2017-2022)
Table 55. Europe Verapamil Sales by Type (2017-2022) & (K Units)
Table 56. Europe Verapamil Sales Market Share by Type (2017-2022)
Table 57. Europe Verapamil Sales by Application (2017-2022) & (K Units)
Table 58. Europe Verapamil Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Verapamil Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Verapamil Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Verapamil Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Verapamil Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Verapamil Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Verapamil Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Verapamil Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Verapamil Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Verapamil
Table 68. Key Market Challenges & Risks of Verapamil
Table 69. Key Industry Trends of Verapamil
Table 70. Verapamil Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Verapamil Distributors List
Table 73. Verapamil Customer List
Table 74. Global Verapamil Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Verapamil Sales Market Forecast by Region
Table 76. Global Verapamil Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Verapamil Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Verapamil Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Verapamil Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Verapamil Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Verapamil Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Verapamil Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Verapamil Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Verapamil Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Verapamil Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Verapamil Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Verapamil Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Verapamil Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Verapamil Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Verapamil Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Verapamil Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Verapamil Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Verapamil Revenue Market Share Forecast by Application (2023-2028)
Table 94. REPLEK FARM Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors
Table 95. REPLEK FARM Verapamil Product Offered
Table 96. REPLEK FARM Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. REPLEK FARM Main Business
Table 98. REPLEK FARM Latest Developments
Table 99. Mylan Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Verapamil Product Offered
Table 101. Mylan Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Abbott Laboratories Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors
Table 105. Abbott Laboratories Verapamil Product Offered
Table 106. Abbott Laboratories Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Abbott Laboratories Main Business
Table 108. Abbott Laboratories Latest Developments
Table 109. YUNGSHIN PHARM IND. CO. LTD Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors
Table 110. YUNGSHIN PHARM IND. CO. LTD Verapamil Product Offered
Table 111. YUNGSHIN PHARM IND. CO. LTD Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. YUNGSHIN PHARM IND. CO. LTD Main Business
Table 113. YUNGSHIN PHARM IND. CO. LTD Latest Developments
Table 114. The Central Pharmaceutical CO.,Ltd.Tianjin Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors
Table 115. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Offered
Table 116. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. The Central Pharmaceutical CO.,Ltd.Tianjin Main Business
Table 118. The Central Pharmaceutical CO.,Ltd.Tianjin Latest Developments
List of Figures
Figure 1. Picture of Verapamil
Figure 2. Verapamil Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Verapamil Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Verapamil Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Verapamil Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsules
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Others
Figure 13. Global Verapamil Sales Market Share by Type in 2021
Figure 14. Global Verapamil Revenue Market Share by Type (2017-2022)
Figure 15. Verapamil Consumed in Hospital Pharmacy
Figure 16. Global Verapamil Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 17. Verapamil Consumed in Retail Pharmacy
Figure 18. Global Verapamil Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 19. Verapamil Consumed in Online Sales
Figure 20. Global Verapamil Market: Online Sales (2017-2022) & (K Units)
Figure 21. Verapamil Consumed in Others
Figure 22. Global Verapamil Market: Others (2017-2022) & (K Units)
Figure 23. Global Verapamil Sales Market Share by Application (2017-2022)
Figure 24. Global Verapamil Revenue Market Share by Application in 2021
Figure 25. Verapamil Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Verapamil Revenue Market Share by Company in 2021
Figure 27. Global Verapamil Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Verapamil Revenue Market Share by Geographic Region in 2021
Figure 29. Global Verapamil Sales Market Share by Region (2017-2022)
Figure 30. Global Verapamil Revenue Market Share by Country/Region in 2021
Figure 31. Americas Verapamil Sales 2017-2022 (K Units)
Figure 32. Americas Verapamil Revenue 2017-2022 ($ Millions)
Figure 33. APAC Verapamil Sales 2017-2022 (K Units)
Figure 34. APAC Verapamil Revenue 2017-2022 ($ Millions)
Figure 35. Europe Verapamil Sales 2017-2022 (K Units)
Figure 36. Europe Verapamil Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Verapamil Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Verapamil Revenue 2017-2022 ($ Millions)
Figure 39. Americas Verapamil Sales Market Share by Country in 2021
Figure 40. Americas Verapamil Revenue Market Share by Country in 2021
Figure 41. United States Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Verapamil Sales Market Share by Region in 2021
Figure 46. APAC Verapamil Revenue Market Share by Regions in 2021
Figure 47. China Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Verapamil Sales Market Share by Country in 2021
Figure 54. Europe Verapamil Revenue Market Share by Country in 2021
Figure 55. Germany Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Verapamil Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Verapamil Revenue Market Share by Country in 2021
Figure 62. Egypt Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Verapamil Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Verapamil in 2021
Figure 68. Manufacturing Process Analysis of Verapamil
Figure 69. Industry Chain Structure of Verapamil
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...